| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.320 | 17.676 | 19.016 | 17.873 | 18.744 | 17.592 | 17.765 | 18.812 | 21.601 | 21.779 |
| Total Income - EUR | 15.321 | 17.677 | 19.016 | 17.891 | 18.745 | 17.593 | 17.765 | 18.831 | 21.602 | 21.779 |
| Total Expenses - EUR | 12.634 | 12.656 | 12.357 | 12.874 | 13.727 | 14.205 | 14.634 | 15.426 | 17.542 | 18.566 |
| Gross Profit/Loss - EUR | 2.688 | 5.021 | 6.659 | 5.017 | 5.018 | 3.388 | 3.131 | 3.405 | 4.060 | 3.213 |
| Net Profit/Loss - EUR | 2.228 | 4.667 | 6.469 | 4.838 | 4.831 | 3.224 | 2.957 | 3.239 | 3.848 | 3.028 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Diopal Laborator S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 41 | 0 |
| Current Assets | 20.171 | 8.369 | 7.485 | 9.475 | 9.035 | 6.466 | 5.297 | 5.501 | 5.632 | 8.029 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 8.856 | 2.976 | 2.711 | 1.634 | 2.153 | 1.764 | 920 | 2.089 | 1.475 | 2.197 |
| Cash | 11.315 | 5.393 | 4.774 | 7.841 | 6.882 | 4.702 | 4.376 | 3.412 | 4.158 | 5.831 |
| Shareholders Funds | 19.437 | 7.205 | 6.985 | 8.471 | 7.870 | 5.777 | 3.553 | 4.167 | 4.700 | 6.496 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 735 | 1.164 | 500 | 1.004 | 1.165 | 689 | 1.744 | 1.344 | 989 | 1.544 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2013 - 2013" | |||||||||
| CAEN Financial Year |
2013
|
|||||||||
Comments - Diopal Laborator S.r.l.